Pharmacy Daily | Ructions on Corum board

ONE of the independent directors of listed pharmacy software supplier Corum Group has written to investors to “put his case” against a motion seeking his removal at the company’s upcoming annual general meeting. Douglas Halley says that shareholders will be asked to vote on his removal at the 25 Nov meeting, and is urging members to attend and support him. He says that the motion for removal comes at the instigation of Corum’s 54% shareholder, Lujeta Pty Ltd, which is beneficially owned by William Paterson. Halley says he’s being removed because of his “exercise of true independence as a director” and says that although Corum has two other independent directors, he is the only one free of any actual or perceived conflict of interest. Halley said that he hasn’t decided whether or not to resign (because if Lujeta votes its majority shareholding he will be removed), but urged minority shareholders to attend to ensure that their best interests continue to be served.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 11 Nov 10
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Nov 10